Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Karthik and her team aimed to use CRISPR as a way to identify and isolate a protein generated by the bacteria that cause Lyme ...

Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...

CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an award of up to $856,250 from Breakthrough T1D, the leading global type 1 ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Altair, a global leader in computational intelligence and now part of leading technology company, Siemens, announced the latest updates to HyperWorks® 2026 software. With significant advances in AI, ...

In the latest allocation of European funding for cutting-edge research, ETH Zurich scientists have performed exceptionally ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

When you look at the big players in medical tech, Siemens Healthineers definitely stands out as a major competitor to GE ...